Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sophiris Bio Inc SPHS

Healthcare Biotechnology
Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:SPHS)

Sophiris Bio To Shut Down Operations

PR Newswire May 18, 2020

Sophiris Bio Announces Nasdaq Delisting

GlobeNewswire March 10, 2020

Sophiris Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

GlobeNewswire November 7, 2019

Sophiris Bio Receives Positive Feedback from FDA Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design

PR Newswire October 21, 2019

Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference

PR Newswire August 30, 2019

Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering

PR Newswire August 30, 2019

Sophiris Bio Announces $4.0 Million Registered Direct Offering

PR Newswire August 27, 2019

Sophiris Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights

PR Newswire August 9, 2019

Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design

PR Newswire June 19, 2019
View More News ››

Opinion & Analysis (EXPM:SPHS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:SPHS)

OTC

Whose paying the annual fee to keep this stock listed and why?
Chrysler_Kid - April 1, 2022

First hand experience with prostate cancer.

$SPHS Season's Greetings! Last year I was diagnosed with prostate cancer and my PSA reading was 6.0. In June 2020 my...
melaurian - December 14, 2020

RE:Very good news today: patient death likely unrelated.

About ime we got SOME good news! Bin in this for years since it was Protox!
nugie - August 29, 2018

Very good news today: patient death likely unrelated.

August 29, 2018 https://sphs2017.wordpress.com
melaurian - August 29, 2018

RE:New High

-I'm looking for new all time highs this year. Of course we will see how things play out. However top line trial results could be...
melaurian - June 10, 2018

New High

Will July 26,2018 test the old high of $8.55 on July 26,2016? Coincides with good news/results at the end of Q2.
2bewild - May 31, 2018
View more Bullboard ››

Prospera Energy Inc.

Prospera Energy Inc.

Prospera Energy Inc. is an energy company based in Western Canada, specializing in the exploration, development, and ...
View More »